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OBJECTIVE — We determined associations between diet soda consumption and risk of
incident metabolic syndrome, its components, and type 2 diabetes in the Multi-Ethnic Study of
Atherosclerosis.
RESEARCHDESIGNANDMETHODS — Dietsodaconsumptionwasassessedbyfood
frequency questionnaire at baseline (2000–2002). Incident type 2 diabetes was identiﬁed at
three follow-up examinations (2002–2003, 2004–2005, and 2005–2007) as fasting glucose
126 mg/dl, self-reported type 2 diabetes, or use of diabetes medication. Metabolic syndrome
(and components) was deﬁned by National Cholesterol Education Program Adult Treatment
Panel III criteria. Hazard ratios (HRs) with 95% CI for type 2 diabetes, metabolic syndrome, and
metabolic syndrome components were estimated, adjusting for demographic, lifestyle, and
dietary confounders.
RESULTS — Atleastdailyconsumptionofdietsodawasassociatedwitha36%greaterrelative
risk of incident metabolic syndrome and a 67% greater relative risk of incident type 2 diabetes
compared with nonconsumption (HR 1.36 [95% CI 1.11–1.66] for metabolic syndrome and
1.67 [1.27–2.20] for type 2 diabetes). Of metabolic syndrome components, only high waist
circumference(men102cmandwomen88cm)andhighfastingglucose(100mg/dl)were
prospectively associated with diet soda consumption. Associations between diet soda consump-
tion and type 2 diabetes were independent of baseline measures of adiposity or changes in these
measures, whereas associations between diet soda and metabolic syndrome were not indepen-
dent of these factors.
CONCLUSIONS — Althoughtheseobservationaldatacannotestablishcausality,consump-
tion of diet soda at least daily was associated with signiﬁcantly greater risks of select incident
metabolic syndrome components and type 2 diabetes.
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T
wo longitudinal cohort studies have
shown positive associations be-
tween diet soda consumption and
incident metabolic syndrome indepen-
dent of baseline measures of adiposity
(1,2). Artiﬁcially sweetened beverages,
such as diet soda, are commonly consid-
ered “benign” because they contribute no
energyandfewnutrientstothediet.Con-
sequently, the previously observed diet
soda–metabolic syndrome associations
aregenerallyspeculatedtobetheresultof
residualconfoundingbyotherdietarybe-
haviors, lifestyle factors, or demographic
characteristics (1,2). Biological mecha-
nisms possibly explaining these associa-
tionsarefewandlargelyfocusonartiﬁcial
sweeteners in beverages/foods increasing
the desire for (and consumption of)
sugar-sweetened, energy-dense beverag-
es/foods (3) or disrupting consumers’
ability to accurately estimate energy in-
take and remaining energy needs (4).
Thus, diet soda consumption may result
in overconsumption, increased body
weight, and consequent metabolic dys-
function. If true, such relations have
important implications for dietary coun-
seling, given the high frequency of diet
beverage consumption by those at high
risk for metabolic dysfunction (5).
Replication of previously observed
diet soda–metabolic syndrome associa-
tions in a distinct cohort would bolster
their credibility and provide further in-
sight into the nature of the relationship.
Previous studies have not addressed asso-
ciations between diet soda and individual
metabolic syndrome components or risk
of type 2 diabetes nor have they fully ad-
dressed potential longitudinal mediators
of these relationships, i.e., changes in ad-
iposity status (body weight and or waist
circumference). Therefore, we evaluated
associations between diet soda consump-
tion and risk of incident metabolic syn-
drome (and metabolic syndrome
components) as well as incident type 2
diabetesintheMulti-EthnicStudyofAth-
erosclerosis (MESA), while considering
the inﬂuence of multiple lifestyle con-
founders, including measures of baseline
adiposity and changes in adiposity.
RESEARCH DESIGN AND
METHODS— MESA is a population-
based study of 6,814 Caucasian, African
American, Hispanic, and Chinese adults,
aged 45–84 years, initiated to investigate
the prevalence and progression of sub-
clinical cardiovascular disease (CVD).
Self-reported race/ethnicity, other demo-
graphics,andlifestyleandclinicalcharac-
teristicswerecollectedinsixﬁeldcenters:
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linois; Forsyth County, North Carolina;
New York, New York; Los Angeles
County, California; and St. Paul, Minne-
sota (6). Each examination cycle spanned
2years,withbaseline(2000–2002)and
three follow-up examinations con-
ducted from 2002–2003, 2004–2005,
and 2005–2007. Institutional review board
approvalwasobtainedatallcenters;allpar-
ticipants gave informed consent.
Type 2 diabetes
Fasting glucose was measured at each ex-
aminationbyratereﬂectancespectropho-
tometry using thin-ﬁlm adaptation of the
glucose oxidase method on the Vitros an-
alyzer (Johnson & Johnson Clinical Diag-
nostics, Rochester, NY). Type 2 diabetes
was deﬁned as self-reported type 2 diabe-
tes, fasting glucose 126 mg/dl (for mil-
limoles per liter, multiply by 0.0555) at
any examination, or use of hypoglycemic
medication.Incidentcasescompriseindi-
vidualswithouttype2diabetesatbaseline
who met any one of the three criteria
listed above at follow-up examinations.
Consistency of the serum glucose assay
over examinations was established by re-
analyzing 200 samples from each of the
four examinations over a short time pe-
riod and then recalibrating the original
observations.
Metabolic syndrome
Metabolic syndrome was deﬁned accord-
ing to the modiﬁed National Cholesterol
Education Program Adult Treatment
Panel III deﬁnition (7) as the presence of
three or more of the following: 1) waist
102(men)or88cm(women),2)trig-
lycerides 150 mg/dl (for millimoles per
liter,multiplyby0.0113),3)HDLcholes-
terol 40 (men) or 50 mg/dl (women)
(for millimoles per liter, multiply by
0.0259), 4) blood pressure 130/85
mmHg or antihypertensive treatment,
and 5) fasting glucose 100 mg/dl or an-
tihyperglycemic treatment. Participants
completed standardized medical history
questionnaires ascertaining medication
use and previous diagnoses and provided
samples for quantiﬁcation of fasting insu-
lin and lipids (8). Waist circumference
was measured at the umbilicus using a
standard tape measure. BMI was calcu-
lated from measured weight in kilograms
divided by the square of height in meters.
Resting seated blood pressure was mea-
sured three times using a Dinamap model
Pro 100 automated oscillometric sphyg-
momanometer (Critikon, Tampa, FL).
The average of the last two measurements
was used in analysis.
Dietary intake
Diet was assessed at the baseline exami-
nation via a food frequency questionnaire
(8,9). Diet soda intake was quantiﬁed
from an item listing “Diet soft drinks, un-
sweetened mineral water” (hereafter re-
ferred to as diet soda). Sugar-sweetened
soda intake was quantiﬁed from an item
listing “Regular soft drinks, soda, sweet-
ened mineral water (not diet), nonalco-
holic beer” (hereafter referred to as sugar-
sweetened soda). Frequency response
options for these items were the follow-
ing:rare/never,1–3/month,1/week,2–4/
week, 5–6/week, 1/day, 2–3/day, 4–5/
day, or 6/day. Participants reported
serving size as small, medium, or large
(weighted as intake frequency  0.5, 
1.0, and  1.5 for small, medium, and
large,respectively)(8).Intakeofdietsoda
or regular soda was characterized as rare/
never, rare/never but 1 serving/week,
1 serving/week but 1 serving/day,
and 1 serving/day. Participants who
provided unreliable dietary information
were excluded from analyses (n  630)
(8).
Statistical analyses
We used Cox proportional hazards re-
gression to calculate hazard ratios (HRs)
formetabolicsyndromeandtype2diabe-
tes (PROC tPHREG in SAS 9.2; SAS Insti-
tute, Cary, NC). We assumed the
incidence date to be the date of the exam-
ination at which type 2 diabetes or meta-
bolicsyndromewasﬁrstidentiﬁed.When
estimating HR for incident type 2 diabe-
tes, we excluded participants with preva-
lent type 2 diabetes (n  859) and those
whose prevalent type 2 diabetes status
was unknown or could not be updated
over follow-up (n  328). When estimat-
ing HR for incident metabolic syndrome,
we excluded individuals with prevalent
metabolic syndrome (n  2,241) and
those whose metabolic syndrome status
was unknown at baseline or could not be
updated over follow-up (n  226). When
estimating HR for a given metabolic syn-
drome component, we excluded partici-
pants meeting the criteria for that
component at baseline. Sample sizes for
these analyses are shown in RESULTS.
Model 1 adjusted for baseline age,
sex, race/ethnicity, examination site, and
energy intake. Model 2 added additional
possible socioeconomic or lifestyle con-
founders: attained education (less than,
equal to, or more than high school), time
spent in inactive and active pursuits dur-
ing leisure (MET-minutes per week),
smoking status (current, former, or never
smoker), pack-years, and regular dietary
supplement use (weekly use or more
versus nonweekly use). We also explored
the impact of adjustment for various di-
etary factors (speciﬁcally, those associ-
ated with both diet soda consumption
andtype2diabetesand/ormetabolicsyn-
drome in ours or previous studies), such
as food intakes (servings per day of whole
grain bread/rice/cereal/pasta, nuts/seeds,
fruit, vegetables, white potatoes, reﬁned
grain bread/rice/cereal/pasta, salty
snacks, desserts, red meat, processed
meat, high-fat dairy products, low-fat
dairy products, sugar-sweetened soda,
and coffee) or nutrient intakes (ﬁber, cal-
cium, phosphorus, potassium, magne-
sium, and sodium). Finally, to assess the
contribution of adiposity, we adjusted for
1) baseline waist circumference (continu-
ous, in centimeters), baseline BMI (con-
tinuous), or both (single model); 2)
change in waist circumference or body
weight (most recent measurement 
baseline measurement); and 3) stratiﬁca-
tion by BMI (25 and 25 kg/m
2).
HRs and 95% CIs are presented rela-
tive to the lowest consumption category.
We considered CIs excluding 1.00 statis-
tically signiﬁcant.
RESULTS
Approximately 14% of participants con-
sumed 1 serving of diet soda daily
(19.4% of whites, 8.6% of blacks, 11.9%
of Hispanics, and 5.4% of Chinese),
whereas 59% of participants reported
neverconsumingdietsoda.Fourteenper-
cent consumed 1 serving of sugar-
sweetened soda daily (10.7% of whites,
20.7%ofblacks,17.7%ofHispanics,and
3.4% of Chinese), whereas 45% never
consumed sugar-sweetened soda. Twen-
ty-four percent did not consume either
beverage; only 2% reported consuming
1 serving of both at least daily. Over
follow-up, 871 cases of incident meta-
bolic syndrome (22.5%) and 413 cases of
incident type 2 diabetes (8.2%) were
identiﬁed. Demographic and lifestyle
characteristics are shown in Table 1.
Diet soda and risk of metabolic
syndrome and type 2 diabetes
Compared with nonconsumers, the risk
of metabolic syndrome was 36% greater
in those consuming 1 serving of diet
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graphic characteristics and energy intake
(model2,Table2).Relativeriskestimates
changed little after additional adjustment
for other dietary factors (foods or nutri-
ents, data not shown). However, with ad-
justment for baseline measures of
adiposity (waist circumference and/or
BMI), the association was no longer sig-
niﬁcant (Table 2). Similarly, the associa-
tion was strongly attenuated when
adjusted for change in waist circumfer-
ence or change in body weight between
baseline and examination 4 (data not
shown).
Table 1—Characteristics of 5,011 participants free of prevalent type 2 diabetes according to diet soda consumption categories in MESA
Rare or never
 rare/never but 1
serving per week
1 serving/week to 1
serving/day 1 serving/day P*
n 2,961 455 914 681
Median diet soda intake (serving/day) 0.0 0.1 0.4 2.5
Sex (% male) 48.9 43.7 43.7 48.5 0.11
Age (years) 62.5  0.2 61.2  0.5 61.5  0.3 58.9  0.4 0.001
Race/ethnicity 0.001
% white 34.0 46.6 58.6 62.11
% African American 27.0 23.7 15.4 17.8
% Hispanic 22.7 18.0 21.1 15.3
% Chinese 16.3 11.7 4.8 4.9
High school degree (%) 80.3 91.2 92.5 88.5 0.001
Active leisure (MET-min/week) 2,357  56 2,762  143 2,746  101 2,670  117 0.001
Inactive leisure (MET-min/week) 1,665  21 1,692  52 1,744  37 1,628  43 0.73
Smoking (% current) 15.6 10.8 13.3 12.0 0.006
Cigarette pack-years 11.5  0.4 8.4  1.0 10.1  0.7 12.3  0.9 0.87
Weekly supplement use (% current) 58.5 54.5 58.9 57.9 0.42
Fasting insulin (mg/dl) 44  0.7 44  1.4 43  0.7 45  1.4 0.80
Fasting glucose (mg/dl) 89.9  0.2 88.7  0.5 89.1  0.3 89.2  0.4 0.03
BMI (kg/m
2) 27.3  0.1 28.3  0.2 28.5  0.2 29.3  0.2 0.001
Waist circumference (cm) 95.6  0.3 97.2  0.6 98.3  0.5 100.6  0.5 0.001
Dietary intake†
Energy (kcal/day) 1,673  14 1,608  36 1,631  25 1,871  29 0.001
Protein (g/day) 65.5  0.3 69.2  0.7 68.3  0.5 68.0  0.6 0.001
Total fat (g/day) 65.4  0.2 63.5  0.6 64.0  0.4 63.4  0.5 0.001
Saturated fat (g/day) 20.7  0.1 20.3  0.3 20.5  0.2 20.3  0.2 0.11
Monounsaturated fat (g/day) 23.9  0.1 23.1  0.3 23.5  0.2 23.2  0.2 0.001
Polyunsaturated fat (g/day) 14.9  0.1 14.0  0.2 13.9  0.2 13.9  0.2 0.001
Trans fat (g/day) 3.3  0.03 3.3  0.1 3.5  0.05 3.4  0.1 0.002
Carbohydrate (g/day) 210  0.7 209  2 207  1 207  1 0.007
Fiber 17.6  0.1 18.7  0.3 18.2  0.2 17.8  0.2 0.07
Calcium (mg/day) 746  7 799  18 794  13 769  15 0.006
Potassium (mg/day) 2,645  12 2,813  31 2,789  22 2,694  26 0.001
Magnesium (mg/day) 258  1 273  3 274  2 269  35 0.001
Phosphorus (mg/day) 1,057  5 1,112  13 1,121  9 1,143  11 0.001
Sodium (mg/day) 2,345  11 2,393  28 2,408  20 2,431  23 0.001
Whole grains (servings/day) 0.56  0.01 0.66  0.03 0.66  0.02 0.62  0.02 0.001
Nuts/seeds 0.28  0.01 0.29  0.02 0.31  0.01 0.29  0.02 0.12
Fruit 1.8  0.03 2.0  0.1 1.9  0.1 1.9  0.1 0.04
Vegetables 2.3  0.02 2.4  0.1 2.3  0.04 2.3  0.1 0.57
White potatoes 0.20  0.004 0.18  0.01 0.20  0.01 0.20  0.01 0.66
White bread, rice, pasta, cereal 1.3  0.01 1.2  0.04 1.2  0.03 1.2  0.03 0.001
Salty snacks 0.21  0.01 0.22  0.01 0.24  0.01 0.22  0.01 0.05
Desserts 0.31  0.01 0.29  0.02 0.34  0.01 0.36  0.02 0.006
Low-fat dairy products 0.71  0.02 0.91  0.05 0.89  0.04 0.81  0.04 0.001
High-fat dairy products 0.53  0.01 0.50  0.03 0.46  0.02 0.47  0.02 0.001
Red meat 0.38  0.01 0.39  0.01 0.38  0.01 0.37  0.01 0.33
Processed meat 0.18  0.004 0.15  0.01 0.16  0.01 0.15  0.01 0.004
Nondiet soda 0.45  0.02 0.31  0.04 0.28  0.03 0.39  0.03 0.001
Coffee 1.1  0.03 1.2  0.1 1.5  0.1 1.4  0.1 0.001
DataaremeansSEor%.Characteristicsofparticipantsfreeofprevalentmetabolicsyndrome(n3,878)acrosscategoriesofdietsodaconsumptionweresimilar.
*P for linear trend calculated with the categorical variable modeled continuously. †With the exception of energy intake, all dietary variables are adjusted for
kilocalories per day.
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ticipants with any metabolic syndrome
component at baseline (leaving a much
smaller sample of 1,078 participants and
46 incident cases of metabolic syn-
drome), the HR comparing extreme diet
soda consumption categories was greater
(1.54 [95% CI 0.65–3.65], model 2) but
not statistically signiﬁcant.
Daily consumers of diet soda had a
67% elevated risk of type 2 diabetes com-
pared with nonconsumers with adjust-
ment for demographics and lifestyle
factors(model2,Table2).Adjustmentfor
other dietary factors did not markedly
change risk estimates (data not shown).
With adjustment for baseline differences
in waist circumference and/or BMI, HRs
for type 2 diabetes were slightly attenu-
ated but remained statistically signiﬁcant
(Table 2). The association also remained
statistically signiﬁcant with adjustment
for change in waist circumference (HR
1.08 [95% CI 0.75–1.57], 1.45 [1.12–
1.89], and 1.69 [1.28–2.22] across in-
creasing diet soda consumption
categories compared with nonconsump-
tion, respectively). Results were similar
when adjusted for change in body weight
(data not shown).
With stratiﬁcation for BMI (25 vs.
25 kg/m
2), HRs were similar in both
strata for metabolic syndrome and type 2
diabetes, although there were few inci-
dentcasesandmuchlargerconﬁdencein-
tervals in the BMI 25 kg/m
2 strata,
comparing extreme intake categories for
metabolic syndrome (HR 2.2 [95% CI
1.10–4.51] with BMI 25 kg/m
2 and
1.48 [1.07–2.05] with BMI 25 kg/m
2)
and for type 2 diabetes (1.94 [0.87–4.35]
with BMI 25 kg/m
2 and 1.54 [1.15–
2.07] with BMI 25 kg/m
2).
Sugar-sweetened soda and risk of
metabolic syndrome and type 2
diabetes
Although our primary analyses focused
ondietsodaintake,wealsoestimatedcor-
responding risks for metabolic syndrome
and type 2 diabetes according to con-
sumption of sugar-sweetened soda. Data
showed no signiﬁcant associations be-
tween sugar-sweetened soda consump-
tion and risk of either metabolic
syndrome or type 2 diabetes (data not
shown).
If risk estimates for type 2 diabetes
across diet soda categories were calcu-
lated in only the participants who did not
consume sugar-sweetened soda (n 
2,245), the association with diet soda
consumption remained signiﬁcant, al-
though CIs were wide (HR 1.43 [0.79–
2.61],1.76[1.18–2.63],and2.23[1.49–
3.34], across increasing diet soda
consumption categories compared with
nonconsumption, respectively). This re-
sult was also true for metabolic syndrome
(1.63 [1.13–2.36], 1.36 [1.02–1.81], and
1.81 [1.36- 2.42] across increasing diet
soda consumption categories compared
with nonconsumption, respectively, n 
1,773).
Metabolic syndrome component
Compared with nonconsumers, individ-
uals consuming 1 daily serving of diet
soda had a signiﬁcantly greater risk of de-
velopinghighwaistcircumference(102
cm if male and 88 cm if female) or high
fasting glucose (100 mg/dl) during fol-
low-up(HR1.59[95%CI1.23–2.07]and
1.28 [1.08–1.52] for high waist circum-
ference and high fasting glucose, respec-
tively) (Table 3). Diet soda consumption
was not associated with the development
ofothermetabolicsyndromecomponents
(Table 3). As an alternative approach to
address the same question, we also eval-
uated the amount of attenuation that oc-
curred when metabolic syndrome HRs
wereadjustedforbaselinemeasuresofin-
dividual metabolic syndrome compo-
nents. Similarly, the largest amount of
attenuation occurred when HRs for inci-
dent metabolic syndrome were adjusted
for baseline waist circumference or base-
line fasting glucose concentration (com-
paringindividualsconsuming1serving
of diet soda versus nonconsumers: 1.18
[0.96–1.44]adjustedforwaistcircumfer-
ence; 1.23 [1.00–1.51] adjusted for glu-
cose; 1.37 [1.12–1.68] adjusted for HDL
cholesterol; 1.39 [1.14–1.70] adjusted
for triglycerides; and 1.29 [1.06–1.58]
adjusted for systolic and diastolic blood
pressure).
Interactions
There were no signiﬁcant interactions be-
tween diet soda or sugar-sweetened soda
and age, sex, BMI, or waist circumference
Table 2—Risk of incident metabolic syndrome and type 2 diabetes according to diet soda consumption categories in participants from MESA
Rare or never
 rare/never but 1
serving/week
1 serving/week to 1
serving/day 1 serving/day Ptrend*
Metabolic syndrome
n 2,288 367 722 501
Cases 478 95 169 129
HR (95% CI) 1.00† 1.34 (1.07–1.67) 1.20 (1.00–1.43) 1.31 (1.07–1.60) 0.003
1.00‡ 1.42 (1.14–1.78) 1.28 (1.06–1.53) 1.36 (1.11–1.66) 0.001
1.00§ 1.31 (1.05–1.64) 1.13 (0.94–1.37) 1.18 (0.96–1.44) 0.06
1.00 1.30 (1.04–1.62) 1.15 (0.95–1.38) 1.17 (0.96–1.44) 0.06
Type 2 diabetes
n 2,961 455 914 681
Cases 221 33 84 75
HR (95% CI) 1.00† 1.06 (0.73–1.52) 1.39 (1.07–1.80) 1.63 (1.24–2.13) 0.001
1.00‡ 1.10 (0.76–1.59) 1.46 (1.12–1.89) 1.67 (1.27–2.20) 0.001
1.00§ 1.00 (0.69–1.45) 1.23 (0.94–1.60) 1.40 (1.06–1.84) 0.01
1.00 0.98 (0.68–1.42) 1.25 (0.96–1.62) 1.38 (1.04–1.82) 0.01
n  5,011. *Ptrend with categorical variable modeled continuously. †Model 1 adjusted for study site, age, sex, race/ethnicity, and energy intake. ‡Model 2 adjusted
for the variables in model 1 above plus education, physical activity, smoking status, pack-years, and weekly or more supplement use. §Adjusted for the variables in
model2abovewaistcircumference(centimeters).Adjustedforthevariablesinmodel2abovewaistcircumference(centimeters)andBMI(weightinkilograms
divided by the square of height in meters).
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drome, metabolic syndrome compo-
nents, or type 2 diabetes. Results were
also similar across race/ethnic strata. Fur-
thermore, if Chinese were excluded from
analyses (a group in which alternative
metabolic syndrome criteria have been
suggested),resultswerequitesimilar;i.e.,
greater diet soda intake remained associ-
ated with greater risk of type 2 diabetes
and metabolic syndrome (data not
shown).
CONCLUSIONS — In MESA, diet
soda consumption was positively associ-
ated with both incident metabolic syn-
drome and type 2 diabetes. Associations
between diet soda and risk of type 2 dia-
betes were of greater magnitude than the
associations observed between diet soda
andmetabolicsyndrome.Consistentwith
these ﬁndings, diet soda was associated
with development of high fasting glucose
and high waist circumference during fol-
low-up but not with other metabolic syn-
drome components, suggesting that in
this analysis, metabolic syndrome associ-
ations were driven more by a pre-diabetic
condition than the “syndrome” per se.
The frequency of diet beverage consump-
tion in the general population and the
even greater reported consumption of
dietbeveragesinindividualsathighrisk
for these conditions make dissemina-
tion of these ﬁndings to a wider audi-
ence imperative.
Despite accumulating evidence of the
existence of these associations (1,2), we
are cautious not to conclude causality be-
tween diet soda and the diabetic or pre-
diabetic condition. The possibility of
confounding by other dietary and life-
style/behavioral factors cannot be ex-
cluded from these observational studies.
We pose three questions when interpret-
ingourresults:twothatarepredicatedon
an assumption of causality and one that is
not dependent on a causal interpretation
of these ﬁndings.
Is the relation between diet soda and
metabolic disease mediated through
changes in body weight or
composition?
An association between diet soda con-
sumption and subsequent weight gain is
plausible. First, it has been hypothesized
that artiﬁcial sweeteners may increase
hedonistic desires for sweetness and
more energy-dense foods (10–12). Sec-
ond, overconsumption of other foods/
beverages may also occur in conjunction
with diet beverage consumption owing to
overestimation of the number of calories
saved by substituting diet beverages for
sugar-sweetenedbeverages(4).Third,the
association between diet beverages and
weightgainmaybebiasedbyearlyaware-
ness of energy imbalance, i.e., diet bever-
ageconsumptionmayserveasaproxyfor
early(failed)attemptstomaintainweight.
Nevertheless, empirical data have not
universally supported these hypotheses.
Although data from one observational
study showed that women who con-
sumed 5.8 g saccharin daily gained
slightly more weight than nonconsumers
over2years(13),experimentaldatashow
thatparticipantsrandomlyassignedtodi-
etary regimens that include artiﬁcially
sweetened foods and beverages do not
gain more weight or consume more en-
ergy compared with those randomly as-
signed to sugar-sweetened food/beverage
regimens(14–22).However,theidealde-
sign, one that is randomized and long-
term, is notably lacking. In the current
study, we found that the associations be-
tween diet beverage consumption and
risk of type 2 diabetes were attenuated,
but remained signiﬁcant, when adjusted
for baseline BMI or waist circumference
or changes in body weight or waist cir-
cumference across examinations. There-
fore, our data do not indicate that a
change in body weight or fat distribution
Table 3—Risk of developing metabolic syndrome components according to diet soda intake categories in participants from MESA
Rare or never
More often than rare/never
but 1 serving/week
1 serving/week to 1
serving/day 1 serving/day
Blood pressure*
n 1,990 322 602 449
Cases 512 74 144 113
HR (95% CI)† 1.00 (model 2) 1.07 (0.83–1.37) 1.11 (0.91–1.34) 1.17 (0.95–1.45)
Waist circumference*
n 1,544 208 399 277
Cases 282 44 93 81
HR (95% CI)† 1.00 (model 2) 1.13 (0.82–1.57) 1.22 (0.95–1.55) 1.59 (1.23–2.07)
HDL cholesterol*
n 1,881 306 609 434
Cases 604 97 173 127
HR (95% CI)† 1.00 (model 2) 1.12 (0.88–1.44) 0.96 (0.78–1.17) 1.05 (0.84–1.30)
Triglycerides*
n 2,143 344 666 476
Cases 499 78 156 115
HR (95% CI)† 1.00 (model 2) 1.05 (0.82–1.33) 1.10 (0.91–1.33) 1.04 (0.84–1.28)
Fasting glucose*
n 2,453 400 793 584
Cases 664 97 215 177
HR (95% CI)† 1.00 (model 2) 0.97 (0.78–1.21) 1.13 (0.96–1.32) 1.28 (1.08–1.52)
*Metabolicsyndromecomponentsaredeﬁnedasfollows:highbloodpressure:systolicbloodpressure130mmHgordiastolicbloodpressure85mmHgortaking
antihypertensive mediation; high waist circumference: 102 cm if male or 88 cm if female; low HDL cholesterol: 40 mg/dl if male or 50 mg/dl if female; high
triglycerides: 150 mg/dl; high fasting glucose: 100 mg/dl. †Model 2 adjusted for study site, age, sex, race/ethnicity, energy intake education, physical activity,
smoking status, pack-years, and weekly supplement use or more.
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beverage consumption and risk of type 2
diabetes. However, associations between
diet soda and metabolic syndrome were
strongly attenuated when adjusted for
these measures of adiposity. Consistent
with these data, only the metabolic syn-
drome components high waist circumfer-
ence and high fasting glucose were
associated with prospectively reported
diet soda consumption. These results in-
dicate that associations between diet soda
and our outcomes are largely mediated
by changes in adiposity and fasting glu-
cose, pre-diabetic, or diabetic conditions
and not the totality of the metabolic
syndrome.
Could artiﬁcial sweetener (the con-
stituent unique from sugar-sweetened
soda)adverselyaffectbiologicalprocesses
related to insulin resistance, glucose reg-
ulation,andadiposity?Overthelifeofthe
MESAcohort,severalartiﬁcialsweeteners
for sweetening diet beverages have been
usedbythesodaindustry.Thesweeteners
most commonly used in diet beverages had
alsochangedfromtheinitiationofMESAto
themostrecentexamination.Thesedynam-
icsmakeitdifﬁculttoattributeourﬁndings
to the biological effects of a particular artiﬁ-
cial sweetener. Mechanistic studies in ran-
domized, controlled settings addressing
how artiﬁcial sweeteners consumed from
diet beverages affect early markers of meta-
bolic dysfunction are lacking (especially
considering true-to-life exposure to multi-
plesweeteners).Datasuchasoursandthose
that preceded ours (1,2), suggest that such
research is warranted. Current literature ar-
ticles provide data on single sweeteners
only, mostly aspartame (12,14,16,17,19–
24),withafewusingsaccharin(11,16),and
none using sucralose, which was more re-
cently introduced to the beverage market.
Only one study used a combination of arti-
ﬁcialsweeteners(butdidnotincludesucra-
lose) (15), and no studies were long term
nor did they include measures of glycemic
control or insulin sensitivity.
Is diet soda a marker for an
unhealthy lifestyle and/or dietary
pattern that collectively leads to
metabolic dysfunction?
It is known that differences in consump-
tion of a particular food are paralleled by
differences in consumption of other
foods. In the current study, dietary pat-
terns of diet beverage consumers and
nonconsumers were different in several
respects (i.e., regular diet beverage con-
sumers ate more whole grains, fruit, low-
fat dairy products, desserts, and coffee
but less high-fat dairy products, pro-
cessed meat, reﬁned grains, and sugar-
sweetened soda). These differences are
consistent with dietary patterns that have
been independently associated with a
lower risk of metabolic syndrome or type
2 diabetes (1). Analogously, individuals
choosing to consume diet soda probably
follow other healthy behaviors that inﬂu-
ence metabolic syndrome and type 2 dia-
betes risk. These dietary and lifestyle
factors are all potential confounders that
may be difﬁcult to accurately characterize
in epidemiological studies such as ours.
However, failure to adjust fully for these
protective factors would mask a positive
association between diet soda and meta-
bolic dysfunction (i.e., all are positive
confounders).
Limitations of our estimation of diet
sodaorartiﬁcialsweetenerexposureshould
be mentioned. Our food frequency ques-
tionnaire ascertained diet soda consump-
tion from a question that combined
unsweetened mineral water and diet soda.
However, we suspect that the true associa-
tionbetweendietsodaandoutcomeswould
probably be stronger than observed associ-
ations due to dilution by the inclusion of
unsweetened mineral water. Artiﬁcial
sweeteners are found in many types of pur-
chased foods and are commonly added by
the individual to other beverages (e.g., cof-
fee). Therefore, random misclassiﬁcation of
artiﬁcial sweetener exposure may exist, al-
though diet soda consumers may also be
more likely to consume other artiﬁcially
sweetened foods.
In summary, daily diet soda con-
sumption was associated with signiﬁ-
cantly greater risks of two metabolic
syndrome components (incident high
waist circumference and fasting glucose)
and type 2 diabetes in this large, multi-
ethnic cohort. These results corroborate
ﬁndings from the Atherosclerosis Risk in
Communities and Framingham studies
and show that stronger adverse associa-
tions exist between diet soda and type 2
diabetes. Diet soda consumption, either
independently or in conjunction with
other dietary and lifestyle behaviors, may
lead to weight gain, impaired glucose
control, and eventual diabetes.
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